Evidence map›Paper›PMID 37707754›Full record

ArticleJournal of neuro-oncology2023

Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma.

Sarah Iglseder, Anna Iglseder, Vincent Beliveau, Johanna Heugenhauser, Elke R Gizewski, Johannes Kerschbaumer, Guenther Stockhammer, Christian Uprimny, Irene Virgolini, Jozsef Dudas and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of neuro-oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Correlation of [EJNMMI research · 2026
    Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Sarah IglsederDepartment of Neurology, Innsbruck Medical University, Innsbruck, Austria.
Anna IglsederDepartment of Geodesy and Geoinformation, Technical University Vienna, Vienna, Austria.
Vincent BeliveauDepartment of Neurology, Innsbruck Medical University, Innsbruck, Austria.
Johanna HeugenhauserDepartment of Neurology, Innsbruck Medical University, Innsbruck, Austria.
Elke R GizewskiNeuroimaging Research Core Facility, Innsbruck Medical University, Innsbruck, Austria.
Johannes KerschbaumerDepartment of Neurosurgery, Innsbruck Medical University, Innsbruck, Austria.
Guenther StockhammerDepartment of Neurology, Innsbruck Medical University, Innsbruck, Austria.
Christian UprimnyDepartment of Nuclear Medicine, Innsbruck Medical University, Innsbruck, Austria.
Irene VirgoliniDepartment of Nuclear Medicine, Innsbruck Medical University, Innsbruck, Austria.
Jozsef DudasDepartment of Otorhinolaryngology, Innsbruck Medical University, Innsbruck, Austria.
Meinhard Nevinny-StickelDepartment of Therapeutic Radiology and Oncology, Innsbruck Medical University, Innsbruck, Austria.
Martha NowosielskiDepartment of Neurology, Innsbruck Medical University, Innsbruck, Austria. Martha.Nowosielski@i-med.ac.at.
Christoph ScherflerDepartment of Neurology, Innsbruck Medical University, Innsbruck, Austria.
Innsbruck Medical University · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThis retrospective study aimed to analyse the correlation between somatostatin receptor subtypes (SSTR 1-5) and maximum standardized uptake value (SUV

methodThe study included 51 patients who underwent MRI and [68Ga]Ga-DOTATOC PET before meningioma surgery. SUV

resultsThe random forest regression model successfully predicted SUV

conclusionSSTR subtypes 2A, 2B, and 5 correlated significantly with SUV

Indexed as

Meningeal NeoplasmsMeningiomaOrganometallic CompoundsHumansMagnetic Resonance ImagingOctreotidePositron-Emission TomographyReceptors, SomatostatinRetrospective StudiesEdotreotideOctreotideOrganometallic CompoundsReceptors, Somatostatin[68Ga]Ga-DOTATOC PETADC mapsMeningiomaRadiomic featuresSUVmax

Identifiers

PMID37707754
PMCPMC10589159
OpenAlexW4386726210

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.